Inactivation of Sag/Rbx2/Roc2 E3 Ubiquitin Ligase Triggers Senescence and Inhibits Kras-Induced Immortalization

Zhao, 2013, Cullin-RING ligases as attractive anti-cancer targets, Curr Pharm Des, 19, 3215, 10.2174/13816128113199990300 Deshaies, 1999, SCF and Cullin/Ring H2-based ubiquitin ligases, Annu Rev Cell Dev Biol, 15, 435, 10.1146/annurev.cellbio.15.1.435 Gu, 2007, SAG/ROC2/Rbx2 is a novel activator protein-1 target that promotes c-Jun degradation and inhibits 12-O-tetradecanoylphorbol-13-acetate-induced neoplastic transformation, Cancer Res, 67, 3616, 10.1158/0008-5472.CAN-06-4020 Tan, 2008, SAG/ROC2/RBX2 is a HIF-1 target gene that promotes HIF-1alpha ubiquitination and degradation, Oncogene, 27, 1404, 10.1038/sj.onc.1210780 Tan, 2010, Disruption of Sag/Rbx2/Roc2 induces radiosensitization by increasing ROS levels and blocking NF-kB activation in mouse embryonic stem cells, Free Radic Biol Med, 49, 976, 10.1016/j.freeradbiomed.2010.05.030 Gu, 2007, SAG/ROC2 E3 ligase regulates skin carcinogenesis by stage-dependent targeting of c-Jun/AP1 and IkappaB-alpha/NF-kappaB, J Cell Biol, 178, 1009, 10.1083/jcb.200612067 Tan, 2011, SAG/RBX2/ROC2 E3 ubiquitin ligase is essential for vascular and neural development by targeting NF1 for degradation, Dev Cell, 21, 1062, 10.1016/j.devcel.2011.09.014 Jia, 2010, Validation of SAG/RBX2/ROC2 E3 ubiquitin ligase as an anticancer and radiosensitizing target, Clin Cancer Res, 16, 814, 10.1158/1078-0432.CCR-09-1592 He, 2008, SAG/ROC2/RBX2 E3 ligase promotes UVB-induced skin hyperplasia, but not skin tumors, by simultaneously targeting c-Jun/AP-1 and p27, Carcinogenesis, 29, 858, 10.1093/carcin/bgn021 Tan, 2006, SAG/ROC-SCFbeta-TrCP E3 ubiquitin ligase promotes pro-caspase-3 degradation as a mechanism of apoptosis protection, Neoplasia, 8, 1042, 10.1593/neo.06568 Huang, 2001, Elevated expression of SAG/ROC2/Rbx2/Hrt2 in human colon carcinomas: SAG does not induce neoplastic transformation, but its antisense transfection inhibits tumor cell growth, Mol Carcinog, 30, 62, 10.1002/1098-2744(200101)30:1<62::AID-MC1014>3.0.CO;2-A Sasaki, 2001, Expression of the sensitive to apoptosis gene, SAG, as a prognostic marker in nonsmall cell lung cancer, Int J Cancer, 95, 375, 10.1002/1097-0215(20011120)95:6<375::AID-IJC1066>3.0.CO;2-L Yang, 2001, Attenuation of ischemia-induced mouse brain injury by SAG, a redox- inducible antioxidant protein, J Cereb Blood Flow Metab, 21, 722, 10.1097/00004647-200106000-00010 Kim, 2010, Transduced Tat-SAG fusion protein protects against oxidative stress and brain ischemic insult, Free Radic Biol Med, 48, 969, 10.1016/j.freeradbiomed.2010.01.023 Tan, 2013, Endothelial deletion of Sag/Rbx2/Roc2 E3 ubiquitin ligase causes embryonic lethality and blocks tumor angiogenesis, Oncogene Li, 2014, Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis, J Clin Invest, 124, 835, 10.1172/JCI70297 Campisi, 2007, Cellular senescence: when bad things happen to good cells, Nat Rev Mol Cell Biol, 8, 729, 10.1038/nrm2233 Serrano, 1997, Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a, Cell, 88, 593, 10.1016/S0092-8674(00)81902-9 Sun, 2013, Functional characterization of SAG/RBX2/ROC2/RNF7, an antioxidant protein and an E3 ubiquitin ligase, Protein Cell, 4, 103, 10.1007/s13238-012-2105-7 Perez-Benavente, 2013, GSK3-SCF(FBXW7) targets JunB for degradation in G2 to preserve chromatid cohesion before anaphase, Oncogene, 32, 2189, 10.1038/onc.2012.235 Passegue, 2000, JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression, EMBO J, 19, 2969, 10.1093/emboj/19.12.2969 Soucy, 2009, An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer, Nature, 458, 732, 10.1038/nature07884 Hayflick, 1961, The serial cultivation of human diploid cell strains, Exp Cell Res, 25, 585, 10.1016/0014-4827(61)90192-6 Tuveson, 2004, Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects, Cancer Cell, 5, 375, 10.1016/S1535-6108(04)00085-6 Jackson, 2001, Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras, Genes Dev, 15, 3243, 10.1101/gad.943001 Itahana, 2007, Methods to detect biomarkers of cellular senescence: the senescence-associated beta-galactosidase assay, Methods Mol Biol, 371, 21, 10.1007/978-1-59745-361-5_3 Deng, 2008, Telomere dysfunction and tumour suppression: the senescence connection, Nat Rev Cancer, 8, 450, 10.1038/nrc2393 Qi, 2013, mTOR inactivation by ROS-JNK-p53 pathway plays an essential role in Psedolaric acid B induced autophagy-dependent senescence in murine fibrosarcoma L929 cells, Eur J Pharmacol, 715, 76, 10.1016/j.ejphar.2013.05.051 Zamkova, 2013, Ras-induced ROS upregulation affecting cell proliferation is connected with cell type-specific alterations of HSF1/SESN3/p21Cip1/WAF1 pathways, Cell Cycle, 12, 826, 10.4161/cc.23723 Moon, 2010, NADPH oxidase-mediated reactive oxygen species production activates hypoxia-inducible factor-1 (HIF-1) via the ERK pathway after hyperthermia treatment, Proc Natl Acad Sci U S A, 107, 20477, 10.1073/pnas.1006646107 Swaroop, 1999, Expression, purification, and biochemical characterization of SAG, a RING finger redox sensitive protein, Free Radic Biol Med, 27, 193, 10.1016/S0891-5849(99)00078-7 Duan, 1999, SAG, a novel zinc RING finger protein that protects cells from apoptosis induced by redox agents, Mol Cell Biol, 19, 3145, 10.1128/MCB.19.4.3145 Dai, 2006, Erbin inhibits RAF activation by disrupting the sur-8-Ras-Raf complex, J Biol Chem, 281, 927, 10.1074/jbc.M507360200 Hagan, 2006, Raf kinase inhibitor protein regulation of raf and MAPK signaling, Methods Enzymol, 407, 248, 10.1016/S0076-6879(05)07021-7 Yoshida, 2006, Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors, Oncogene, 25, 6056, 10.1038/sj.onc.1209635 Guy, 2009, Sprouty proteins: modified modulators, matchmakers or missing links?, J Endocrinol, 203, 191, 10.1677/JOE-09-0110 Land, 1983, Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes, Nature, 304, 596, 10.1038/304596a0 Serrano, 1996, Role of the INK4a locus in tumor suppression and cell mortality, Cell, 85, 27, 10.1016/S0092-8674(00)81079-X Cichowski, 2001, NF1 tumor suppressor gene function: narrowing the GAP, Cell, 104, 593, 10.1016/S0092-8674(01)00245-8 Le, 2007, Tumor microenvironment and neurofibromatosis type I: connecting the GAPs, Oncogene, 26, 4609, 10.1038/sj.onc.1210261 Bockbrader, 2005, A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells, Oncogene, 24, 7381, 10.1038/sj.onc.1208888 Tan, 2009, RBX1/ROC1 disruption results in early embryonic lethality due to proliferation failure, partially rescued by simultaneous loss of p27, Proc Natl Acad Sci U S A, 106, 6203, 10.1073/pnas.0812425106 Jia, 2011, Induction of p21-dependent senescence by an NAE inhibitor, MLN4924, as a mechanism of growth suppression, Neoplasia, 13, 561, 10.1593/neo.11420 Xie, 2011, Bufalin induces autophagy-mediated cell death in human colon cancer cells through reactive oxygen species generation and JNK activation, Free Radic Biol Med, 51, 1365, 10.1016/j.freeradbiomed.2011.06.016